Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

被引:135
|
作者
Zhou, Jian
Sun, Huichuan
Wang, Zheng
Cong, Wenming
Zeng, Mengsu
Zhou, Weiping
Bie, Ping
Liu, Lianxin
Wen, Tianfu
Kuang, Ming
Han, Guohong
Yan, ZhiPing
Wang, Maoqiang
Liu, Ruibao
Lu, Ligong
Ren, Zhenggang
Zeng, ZhaoChong
Liang, Ping
Liang, Changhong
Chen, Min
Yan, Fuhua
Wang, Wenping
Hou, Jinlin
Ji, Yuan
Yun, Jingping
Bai, Xueli
Cai, Dingfang
Chen, Weixia
Chen, Yongjun
Cheng, Wenwu
Cheng, Shuqun
Dai, Chaoliu
Guo, Wenzhi
Guo, Yabing
Hua, Baojin
Huang, Xiaowu
Jia, Weidong
Li, Qiu
Li, Tao
Li, Xun
Li, Yaming
Li, Yexiong
Liang, Jun
Ling, Changquan
Liu, Tianshu
Liu, Xiufeng
Lu, Shichun
Lv, Guoyue
Mao, Yilei
Meng, Zhiqiang
机构
[1] Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai
[2] Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai
[3] Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai
[4] Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang
[5] Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai
[6] Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou
[7] The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai
[8] Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou
[9] Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing
[10] Graduate School, Beijing University of Chinese Medicine, Beijing
[11] Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin
[12] Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei
[13] Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu
[14] Department of Oncology, West China Hospital, Sichuan University, Chengdu
[15] Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou
[16] Department of General Surgery, Qilu Hospital, Shandong University, Jinan
[17] Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an
[18] The First Hospital of Lanzhou University, Lanzhou
[19] Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai
[20] Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang
[21] Department of Interventional Radiology, Chinese PLA General Hospital, Beijing
[22] Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
[23] Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin
[24] Department of Oncology, Peking University International Hospital, Beijing
[25] Department of Interventional Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou
[26] Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai
[27] Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai
[28] Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai
[29] Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing
[30] Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing
[31] Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou
[32] Institute and Hospital of Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, Beijing
[33] Editorial Department of Chinese Journal of Digestive Surgery, Chongqing
[34] Department of General Surgery, The First Hospital of Jilin University, Jilin
[35] Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
[36] Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing
[37] Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai
[38] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai
[39] Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Nanfang Hospital Southern Medical University, Guangzhou
[40] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning
[41] Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai
[42] Department of Interventional Radiology the First Affiliated Hospital of Xinjiang Medical University, Urumqi
[43] Department of Pathology, Tumor Prevention and Treatment Center, Sun Yat-sen University, Guangzhou
[44] Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai
[45] Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou
[46] Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin
[47] Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai
[48] Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an
[49] Department of Radiology, West China Hospital of Sichuan University, Chengdu
[50] Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai
关键词
Primary liver cancer; hepatocellular carcinoma; guidelines; China; diagnosis; treatment; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONTRAST-ENHANCED ULTRASOUND; RANDOMIZED CONTROLLED-TRIAL; STEREOTACTIC BODY RADIOTHERAPY; PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION; SIROLIMUS-BASED IMMUNOSUPPRESSION; VS. RADIOFREQUENCY ABLATION; SURGICAL RESECTION; OPEN-LABEL;
D O I
10.1159/000530495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Primary liver cancer, around 75%-85% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people.Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China in June 2017, which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new edition (2022 Edition) was written by more than 100 experts in the field of liver cancer in China, which not only reflects the real-world situation in China, but also may re-shape the nationwide diagnosis and treatment of liver cancer. Key Messages: The new guideline aims to encourage the implementation of evidence-based practice, and improve the national average five-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint."
引用
收藏
页码:405 / 444
页数:40
相关论文
共 50 条
  • [31] CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
    Jukic, Lucija Virovic
    Grgurevic, Ivica
    Mikolasevic, Ivana
    Kanizaj, Tajana Filipec
    Milic, Sandra
    Mrzljak, Anna
    Premuzic, Marina
    Hrstic, Irena
    Stromar, Ivana Knezevic
    Ljubicic, Neven
    Ostojic, Rajko
    Shapeski, Sanja Stojsavljevic
    Amerl-Sakic, Vjekoslava
    Markovic, Nina Basic
    Rada, Marko
    Soldo, Dragan
    Sobocan, Nikola
    Lalovac, Milos
    Puljiz, Zeljko
    Podrug, Kristian
    Ladic, Dinko
    ACTA CLINICA CROATICA, 2021, 60 : 36 - 52
  • [32] Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China
    Yan, Yun-Wei
    Liu, Xin-Kui
    Zhang, Shun-Xiang
    Tian, Qing-Feng
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (05) : 859 - 877
  • [33] Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer
    Keane, Florence K.
    Hong, Theodore S.
    CANCER CONTROL, 2017, 24 (03)
  • [34] Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
    Fabi, A.
    Bhargava, R.
    Fatigoni, S.
    Guglielmo, M.
    Horneber, M.
    Roila, F.
    Weis, J.
    Jordan, K.
    Ripamonti, C., I
    ANNALS OF ONCOLOGY, 2020, 31 (06) : 713 - 723
  • [35] 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
    Park, Joong-Won
    Lee, June Sung
    Suh, Kyung-Suk
    Chung, Jin Wook
    Seong, Jinsil
    Kim, Do Young
    Kim, Ji Hoon
    Kim, Hyeong Jun
    Kim, Hwi Young
    Park, Soo Young
    Shim, Joo Hyeon
    Lee, Jeong Hoon
    Lim, Young-Suk
    Lim, Ho Yeong
    Jang, Jeong Won
    Jang, Jae Young
    Jeon, Dae Won
    Ko, Yang Seok
    Kim, Kyung Sik
    Kim, Dong-Sik
    Kim, Seong Hoon
    Kim, Seong Hoon
    Kim, Jong Man
    Yun, Yeong Cheol
    Jeong, Dong Hwan
    Cho, Jai Young
    Koh, Young Hwan
    Kim, Kyeong Min
    Kim, So Yeon
    Kim, Young Hwan
    Lee, In Joon
    Lee, Jeong Min
    Lim, Hyeon Cheol
    Cho, Sung Ki
    Cheon, Ho Jong
    Choi, Jun Il
    Kay, Chul Seung
    Kim, Mi-Sook
    Kim, Tae Hyun
    Park, Hee Chul
    Bae, Sun Hyeon
    Yoon, Sang Min
    Yoon, Won Sup
    Jang, Won Il
    Ryu, Jun Sun
    Kim, Hwi Young
    Lee, Jeong Hoon
    GUT AND LIVER, 2019, 13 (03) : 227 - +
  • [36] 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
    Park, Joong-Won
    Lee, June Sung
    Suh, Kyung-Suk
    Chung, Jin Wook
    Seong, Jinsil
    Kim, Do Young
    Kim, Ji Hoon
    Kim, Hyeong Jun
    Kim, Hwi Young
    Park, Soo Young
    Shim, Joo Hyeon
    Lee, Jeong Hoon
    Lim, Young-Suk
    Lim, Ho Yeong
    Jang, Jeong Won
    Jang, Jae Young
    Jeon, Dae Won
    Ko, Yang Seok
    Kim, Kyung Sik
    Kim, Dong-Sik
    Kim, Seong Hoon
    Kim, Jong Man
    Yun, Yeong Cheol
    Jeong, Dong Hwan
    Cho, Jai Young
    Koh, Young Hwan
    Kim, Kyeong Min
    Kim, So Yeon
    Kim, Young Hwan
    Lee, In Joon
    Lee, Jeong Min
    Lim, Hyeon Cheol
    Cho, Sung Ki
    Cheon, Ho Jong
    Choi, Jun Il
    Kay, Chul Seung
    Kim, Mi-Sook
    Kim, Tae Hyun
    Park, Hee Chul
    Bae, Sun Hyeon
    Yoon, Sang Min
    Yoon, Won Sup
    Jang, Won Il
    KOREAN JOURNAL OF RADIOLOGY, 2019, 20 (07) : 1042 - +
  • [37] Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
    Yang Yinmo
    Bai Xueli
    Bian Dapeng
    Cai Shouwang
    Chen Rufu
    Cao Feng
    Dai Menghua
    Fang Chihua
    Fu Deliang
    Ge Chunlin
    Guo Xiaochao
    Hao Chunyi
    Hao Jihui
    Huang Heguang
    Jian Zhixiang
    Jin Gang
    Li Fei
    Li Haimin
    Li Shengping
    Li Weiqin
    Li Yixiong
    Li Hongzhen
    Liang Tingbo
    Liu Xubao
    Lou Wenhui
    Miao Yi
    Mou Yiping
    Peng Chenghong
    Qin Renyi
    Shao Chenghao
    Sun Bei
    Tan Guang
    Tian Xiaodong
    Wang Huaizhi
    Wang Lei
    Wang Wei
    Wang Weilin
    Wei Junmin
    Wu Heshui
    Wu Wenming
    Wu Zheng
    Xu Jingyong
    Yan Changqing
    Yin Xiaoyu
    Yu Xianjun
    Yuan Chunhui
    Zhang Taiping
    Zhang Jixin
    Zhou Jun
    Zhao Yupei
    胰腺病学杂志(英文), 2021, 04 (02) : 49 - 66
  • [38] Breast Cancer in the Elderly: Retrospective Study on Diagnosis and Treatment According to National Guidelines
    Hamaker, Marije E.
    Schreurs, W. H.
    Uppelschoten, Jeroen M.
    Smorenburg, Carolien H.
    BREAST JOURNAL, 2009, 15 (01) : 26 - 33
  • [39] Guidelines for the diagnosis and treatment of chronic pancreatitis in China (2018 edition)
    Zou, Wen-Bin
    Ru, Nan
    Wu, Hao
    Hu, Liang-Hao
    Ren, Xu
    Jin, Gang
    Wang, Zheng
    Du, Yi-Qi
    Cao, Ya-Nan
    Zhang, Lei
    Chang, Xiao-Yan
    Zhang, Rong-Chun
    Li, Xiao-Bin
    Shen, Yan
    Li, Peng
    Li, Zhao-Shen
    Liao, Zhuan
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (02) : 103 - 109
  • [40] CSH guidelines for the diagnosis and treatment of drug-induced liver injury
    Yu, Yue-cheng
    Mao, Yi-min
    Chen, Cheng-wei
    Chen, Jin-jun
    Chen, Jun
    Cong, Wen-ming
    Ding, Yang
    Duan, Zhong-ping
    Fu, Qing-chun
    Guo, Xiao-yan
    Hu, Peng
    Hu, Xi-qi
    Jia, Ji-dong
    Lai, Rong-tao
    Li, Dong-liang
    Liu, Ying-xia
    Lu, Lun-gen
    Ma, Shi-wu
    Ma, Xiong
    Nan, Yue-min
    Ren, Hong
    Shen, Tao
    Wang, Hao
    Wang, Ji-yao
    Wang, Tai-ling
    Wang, Xiao-jin
    Wei, Lai
    Xie, Qing
    Xie, Wen
    Yang, Chang-qing
    Yang, Dong-liang
    Yu, Yan-yan
    Zeng, Min-de
    Zhang, Li
    Zhao, Xin-yan
    Zhuang, Hui
    HEPATOLOGY INTERNATIONAL, 2017, 11 (03) : 221 - 241